Clearmind Medicine (CMND) FCF Payout Ratio Growth (1y) (2023 - 2026)
Clearmind Medicine (CMND) FCF Payout Ratio Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 68.88% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -31.89% |
| 10 | Clearmind Medicine | 537,435.54 | -13.06 Mn | - | -202.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -202.44% |
| Jan 31, 2026 | 2.81% |
| Jul 31, 2025 | 62.06% |
| Apr 30, 2025 | 45.01% |
| Jan 31, 2025 | 28.07% |
| Jul 31, 2024 | -45.32% |
| Jan 31, 2024 | -475.54% |
| Jul 31, 2023 | 1,027.09% |
| Jan 31, 2023 | 29.88% |